The Effects of Methylphenidate on Symptomatology in Individuals With Borderline Personality Disorder
Status:
NOT_YET_RECRUITING
Trial end date:
2025-03-25
Target enrollment:
Participant gender:
Summary
This study aims to investigate the effects of methylphenidate on symptomatology in individuals with borderline personality disorder. Specifically, it will evaluate whether Concerta is effective in reducing impulsivity, mood instability, and inattention among patients with BPD. Additionally, the study will assess Concerta's safety profile in this population to determine its potential as a supportive pharmacological option in BPD management.